# A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)

> **NCT07704840** · PHASE2 · RECRUITING · sponsor: **Alberto Esquenazi** · enrollment: 42 (estimated)

## Conditions studied

- Post-Stroke Spasticity

## Interventions

- **DRUG:** Administration of BMS-986368
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07704840
- **Lead sponsor:** Alberto Esquenazi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-02
- **Primary completion:** 2027-06
- **Final completion:** 2027-08
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704840, "A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07704840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*